LoRusso P - Search Results

1

A phase I study of gemcitabine and uracil-ftorfar (UFT)/leucovorin.

El-Rayes BF, Zalupski M, Shields AF, Manza SG, LoRusso P, Philip PA. El-Rayes BF, et al. Among authors: lorusso p. Am J Clin Oncol. 2007 Apr;30(2):101-5. doi: 10.1097/01.coc.0000251223.98193.f4. Am J Clin Oncol. 2007. PMID: 17414457 Clinical Trial.

2

Low-dose continuous infusion 5-fluorouracil and cisplatin: phase II evaluation in advanced colorectal carcinoma.

LoRusso P, Pazdur R, Redman BG, Kinzie J, Vaitkevicius V. LoRusso P, et al. Am J Clin Oncol. 1989 Dec;12(6):486-90. doi: 10.1097/00000421-198912000-00005. Am J Clin Oncol. 1989. PMID: 2686394 Review.

3

Phase I study of monoclonal antibody-ricin A chain immunoconjugate Xomazyme-791 in patients with metastatic colon cancer.

LoRusso PM, Lomen PL, Redman BG, Poplin E, Bander JJ, Valdivieso M. LoRusso PM, et al. Am J Clin Oncol. 1995 Aug;18(4):307-12. doi: 10.1097/00000421-199508000-00008. Am J Clin Oncol. 1995. PMID: 7625372 Clinical Trial.

4

Phase I trial of Adozelesin using the treatment schedule of daily x5 every 3 weeks.

Foster BJ, LoRusso PM, Poplin E, Zalupski M, Valdivieso M, Wozniak A, Flaherty L, Kasunic DA, Earhart RH, Baker LH. Foster BJ, et al. Among authors: lorusso pm. Invest New Drugs. 1996;13(4):321-6. doi: 10.1007/BF00873138. Invest New Drugs. 1996. PMID: 8824350 Clinical Trial.

5

Phase II study of pyrazoloacridine in patients with advanced colorectal carcinoma.

Zalupski MM, Philip PA, LoRusso P, Shields AF. Zalupski MM, et al. Among authors: lorusso p. Cancer Chemother Pharmacol. 1997;40(3):225-7. doi: 10.1007/s002800050650. Cancer Chemother Pharmacol. 1997. PMID: 9219505 Clinical Trial.

6

Phase II evaluation of cisplatin and WR2721 for refractory metastatic breast cancer.

Ramnath N, LoRusso P, Simon M, Martino S. Ramnath N, et al. Among authors: lorusso p. Am J Clin Oncol. 1997 Aug;20(4):368-72. doi: 10.1097/00000421-199708000-00009. Am J Clin Oncol. 1997. PMID: 9256891 Clinical Trial.

7

Evaluation of pyrazoloacridine in patients with advanced pancreatic carcinoma.

Zalupski MM, Shields AF, Philip PA, Kraut M, LoRusso P, Heilbrun LK, Vaitkevicius V. Zalupski MM, et al. Among authors: lorusso p. Invest New Drugs. 1998;16(1):93-6. doi: 10.1023/a:1006087114621. Invest New Drugs. 1998. PMID: 9740550 Clinical Trial.

8

Phase I clinical trial of pyrazoloacridine NSC366140 (PD115934).

LoRusso P, Foster BJ, Poplin E, McCormick J, Kraut M, Flaherty L, Heilbrun LK, Valdivieso M, Baker L. LoRusso P, et al. Clin Cancer Res. 1995 Dec;1(12):1487-93. Clin Cancer Res. 1995. PMID: 9815948 Clinical Trial.

9

Phase II study of CI-958 in colorectal cancer.

Shields AF, Philip PA, LoRusso PM, Ferris AM, Zalupski MM. Shields AF, et al. Among authors: lorusso pm. Cancer Chemother Pharmacol. 1999;43(2):162-4. doi: 10.1007/s002800050878. Cancer Chemother Pharmacol. 1999. PMID: 9923823 Clinical Trial.

10

Accrual to breast cancer clinical trials at a university-affiliated hospital in metropolitan Detroit.

Simon MS, Brown DR, Du W, LoRusso P, Kellogg CM. Simon MS, et al. Among authors: lorusso p. Am J Clin Oncol. 1999 Feb;22(1):42-6. doi: 10.1097/00000421-199902000-00011. Am J Clin Oncol. 1999. PMID: 10025379

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

420 results

Search Page

Filters